Company intelligence / Profile preview

Concord Biotech

Ahmedabad, Gujarat, Indiastockdiscovery.s3.amazonaws.com ↗

Ownership: Private
Employees: ~1180
Development stage: Commercial

Overview

Concord Biotech is a commercial-stage company with global sales of APIs and finished formulations in over 70 countries. It has USFDA-approved manufacturing facilities and supplies both generic APIs/formulations as well as contract research/manufacturing services. The company is recognized for its expertise in fermentation-based production of complex molecules such as immunosuppressants, antifungals, antibacterials, oncologics, and nephrology drugs.

Therapeutic areas: OncologyImmunologyNephrologyInfectious Diseases
Modalities: Small moleculeBiologicRecombinant protein (via fermentation)
Industry: Biotech

Partnerships

Works with leading global pharmaceutical companies for API supply/development/distribution but specific partners not named publicly

Beyond the preview

Go deeper on Concord Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Concord Biotech.

Explore the full profile